Contract facts
Small businessDHA SBIR SEQUENTIAL PHASE II, PROPOSAL NO. H2S-0071, TITLED: "DEVELOPING AN IDEAL FIRST USE AGENT TO PREVENT SEPSIS IN TRAUMA WOUNDS DURING CARE UNDER FIRE." is a federal Small business award for Army Med Res Acq Activity held by Altrazeal Life Sciences Inc. Estimated value $1.3M ($1.3M obligated). Current period of performance ends Jun 6, 2027. Last award drew 1 bidder. Place of performance: ADDISON TX. Related solicitation HQ003420RBDST.
DHA SBIR SEQUENTIAL PHASE II, PROPOSAL NO. H2S-0071, TITLED: "DEVELOPING AN IDEAL FIRST USE AGENT TO PREVENT SEPSIS IN TRAUMA WOUNDS DURING CARE UNDER FIRE."
Recompete timing
PublicCurrent PoP ends Jun 6, 2027 (252 days remaining). Agencies typically plan 12–18 months ahead — at 8.3 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on HT942525C0002? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordAltrazeal Life Sciences Inc — $2.8M obligated across 4 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT942525C0002?
HT942525C0002 (DHA SBIR sequential PHASE II proposal) is a Army Med Res Acq Activity award with a potential value of $1.3M, currently held by Altrazeal Life Sciences Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT9425-25-C-0002?
HT9425-25-C-0002 is the dashed form of PIID HT942525C0002 (DHA SBIR sequential PHASE II proposal), held by Altrazeal Life Sciences Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT942525C0002?
Army Med Res Acq Activity awarded HT942525C0002 to Altrazeal Life Sciences Inc (potential $1.3M).
Who is the incumbent on HT942525C0002?
Altrazeal Life Sciences Inc is the incumbent with $2.8M across 4 related awards in SCOUT’s public footprint. The current period of performance ends Jun 6, 2027.
When does Altrazeal Life Sciences Inc’s HT942525C0002 come up for recompete?
SCOUT tracks a period-of-performance end of Jun 6, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on HT942525C0002? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.